Tag: Medication
-
Health insurance open enrollment: Use this ‘algorithm’ to pick a plan, financial advisor says
There are several factors consumers must consider during open enrollment, such as choice, cost and savings options.
-
For the final 10% of cystic fibrosis patients, the breakthrough still hasn’t come
For the final 10% of cystic fibrosis patients who cannot benefit from breakthrough drugs, Emily’s Entourage is funding research to find treatments.
-
Russia plague: How great is the global risk? Maybe low, but infectious disease experts want more data
Uncertainty surrounds the death of an employee at a Russian anti-plague institute. Here’s what infectious disease experts say about how worried you should be.
-
Russian lab worker’s suspected plague death leaves experts puzzled
Russian authorities say the situation is stable and there are no reports of secondary cases.
-
Russia plague: What we know about the suspected case reportedly linked to a lab worker’s death
According to local media reports, as many as 189 people have also been placed under medical observation in Irkutsk in Eastern Russia.
-
BioMarin reports five-year Pompe disease data showing durable motor function
BioMarin shared five-year data showing a combination therapy helped adults with late-onset Pompe disease maintain motor function.
-
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.
-
One drug, many rare diseases. Inside the movement to make rare drug development more profitable
The Ladders to Cures Accelerator aims to develop treatments for multiple rare diseases through shared biological mechanisms.
-
How you can help your grandparents age well, says researcher—it could benefit your well-being too
Being an involved grandparent is associated with positive health outcomes like a lower risk of mortality. Here’s how it can benefit the entire family tree.
-
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
